These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 16199889)
21. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines. Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520 [TBL] [Abstract][Full Text] [Related]
22. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913 [TBL] [Abstract][Full Text] [Related]
23. FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition. Li Y; Zhu X; Zeng Y; Wang J; Zhang X; Ding YQ; Liang L Mol Cancer Res; 2010 Dec; 8(12):1579-90. PubMed ID: 21071512 [TBL] [Abstract][Full Text] [Related]
25. Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo. Schwartz B; Melnikova VO; Tellez C; Mourad-Zeidan A; Blehm K; Zhao YJ; McCarty M; Adam L; Bar-Eli M Oncogene; 2007 Jun; 26(28):4049-58. PubMed ID: 17224907 [TBL] [Abstract][Full Text] [Related]
27. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Hennig G; Behrens J; Truss M; Frisch S; Reichmann E; Birchmeier W Oncogene; 1995 Aug; 11(3):475-84. PubMed ID: 7630631 [TBL] [Abstract][Full Text] [Related]
28. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673 [TBL] [Abstract][Full Text] [Related]
29. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1. Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882 [TBL] [Abstract][Full Text] [Related]
30. Activation and inhibition of the AP-1 complex in human breast cancer cells. Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534 [TBL] [Abstract][Full Text] [Related]
31. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Grille SJ; Bellacosa A; Upson J; Klein-Szanto AJ; van Roy F; Lee-Kwon W; Donowitz M; Tsichlis PN; Larue L Cancer Res; 2003 May; 63(9):2172-8. PubMed ID: 12727836 [TBL] [Abstract][Full Text] [Related]
32. Effects of E-cadherin transfection on gene expression of a gallbladder carcinoma cell line: repression of MTS1/S100A4 gene expression. Kohya N; Kitajima Y; Jiao W; Miyazaki K Int J Cancer; 2003 Mar; 104(1):44-53. PubMed ID: 12532418 [TBL] [Abstract][Full Text] [Related]
33. Loss of intercellular adhesion activates a transition from low- to high-grade human squamous cell carcinoma. Margulis A; Zhang W; Alt-Holland A; Pawagi S; Prabhu P; Cao J; Zucker S; Pfeiffer L; Garfield J; Fusenig NE; Garlick JA Int J Cancer; 2006 Feb; 118(4):821-31. PubMed ID: 16152579 [TBL] [Abstract][Full Text] [Related]
36. DN-R175H p53 mutation is more effective than p53 interference in inducing epithelial disorganization and activation of proliferation signals in human carcinoma cells: role of E-cadherin. Rieber M; Strasberg Rieber M Int J Cancer; 2009 Oct; 125(7):1604-12. PubMed ID: 19507255 [TBL] [Abstract][Full Text] [Related]
37. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. Islam S; Carey TE; Wolf GT; Wheelock MJ; Johnson KR J Cell Biol; 1996 Dec; 135(6 Pt 1):1643-54. PubMed ID: 8978829 [TBL] [Abstract][Full Text] [Related]
38. Coordinated functions of E-cadherin and transforming growth factor beta receptor II in vitro and in vivo. Andl CD; Fargnoli BB; Okawa T; Bowser M; Takaoka M; Nakagawa H; Klein-Szanto A; Hua X; Herlyn M; Rustgi AK Cancer Res; 2006 Oct; 66(20):9878-85. PubMed ID: 17047049 [TBL] [Abstract][Full Text] [Related]
39. Vimentin expression in human squamous carcinoma cells: relationship with phenotypic changes and cadherin-based cell adhesion. Islam S; Kim JB; Trendel J; Wheelock MJ; Johnson KR J Cell Biochem; 2000 Apr; 78(1):141-50. PubMed ID: 10797573 [TBL] [Abstract][Full Text] [Related]
40. The role of E-cadherin and scatter factor in tumor invasion and cell motility. Behrens J; Weidner KM; Frixen UH; Schipper JH; Sachs M; Arakaki N; Daikuhara Y; Birchmeier W EXS; 1991; 59():109-26. PubMed ID: 1833225 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]